Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2B | P29275 | 2/20 | 0.31 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL961942 | 0.94 | PDE4A (0.31) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL25558586 | 0.87 | — | — | |
| SCHEMBL14865773 | 0.87 | — | — | |
| SCHEMBL26090744 | 0.85 | — | — | |
| SCHEMBL3402639 | 0.82 | LMNA (0.32) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL14865754 | 0.81 | — | — | |
| SCHEMBL1252565 | 0.81 | CYP3A4 (0.50) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL17750829 | 0.81 | CYP3A4 (0.50) | ADORA2BPDE4AADORA2APDE4BPDE4C | |
| SCHEMBL17264691 | 0.81 | — | — | |
| SCHEMBL18099427 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7825243-B2 | Process for the production of isocyanatosilane and silylisocyanurate | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-11-02 | — | — | US | claimed |
| EP-1885731-B1 | PROCESS FOR THE PRODUCTION OF ISOCYANATOSILANE AND SILYLISOCYANURATE | MOMENTIVE PERFORMANCE MAT INC (US) | 2009-11-11 | — | — | EP | claimed |
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | GENERAL ELECTRIC COMPANY | 2006-12-07 | — | — | US | claimed |
| US-7060849-B1 | Method for production of isocyanatosilanes | GENERAL ELECTRIC COMPANY (US) | 2006-06-13 | — | — | US | claimed |
| US-7825243-B2 | Process for the production of isocyanatosilane and silylisocyanurate | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2010-11-02 | — | — | US | disclosed |
| EP-1885731-B1 | PROCESS FOR THE PRODUCTION OF ISOCYANATOSILANE AND SILYLISOCYANURATE | MOMENTIVE PERFORMANCE MAT INC (US) | 2009-11-11 | — | — | EP | disclosed |
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | GENERAL ELECTRIC COMPANY | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060276644-A1 | Process for the production of isocyanatosilane and silylisocyanurate | SI, TST, PCMT1 | ADORA2B 4876/4885PDE4A 4868/4885ADORA2A 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.